← FDA Warning Letters

Azurity Pharmaceuticals, Inc.

FDA Warning Letter · 2024-09-24 · Center for Drug Evaluation and Research (CDER)

Letter

Company
Azurity Pharmaceuticals, Inc.
Posted Date
2024-09-24
Letter Issue Date
2024-09-20
Issuing Office
Center for Drug Evaluation and Research (CDER)

Subject

CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug

Source

Authoritative
FDA Warning Letters
Machine
JSON-LD · Markdown